Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD
10.03
+0.87 (9.50%)
Aug 12, 2022 4:00 PM EDT - Market closed

Stock Price Forecast

According to 14 stock analysts, the average 12-month stock price forecast for GLUE stock is $24.92, which predicts an increase of 148.45%. The lowest target is $15.15 and the highest is $39.9. On average, analysts rate GLUE stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $15.15 $24.92 $21.42 $39.9
Change +51.05% +148.45% +113.56% +297.81%

Analyst Ratings

The average analyst rating for GLUE stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Mar '22Apr '22May '22Jun '22Jul '22Aug '22
Strong Buy 333333
Buy 777777
Hold 334444
Sell 000000
Strong Sell 000000
Total 131314141414

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.25
EPS Next Year
-2.66
Year 20192020202120222023202420252026
Revenue
--------
Revenue Growth
--------
EPS
-1.55-23.65-2.96-2.25-2.66-3.04-2.49-2.09
EPS Growth
--------
No. Analysts ---1010955

Revenue Forecast

Revenue 20222023202420252026
High n/a n/a n/a n/a n/a
Avg n/a n/a n/a n/a n/a
Low n/a n/a n/a n/a n/a

Revenue Growth

Revenue Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -

EPS Forecast

EPS 20222023202420252026
High -2.24 -2.52 -2.67 -2.62 -2.17
Avg -2.25 -2.66 -3.04 -2.49 -2.09
Low -2.32 -2.66 -3.39 -2.42 -2.03

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -